At The Crossroads, Part 5: The Uncomfortable Math Of Hep C Treatment

What’s the price of a human life? Many of us would say each life is priceless. But health economists sometimes have a number in mind.

Want to know what that number is?

In this part of our series “At the Crossroads: The Rise of Hepatitis C and The Fight To Stop It,” we'll tell you that - and more. We go beyond the high price of new hepatitis C drugs  to ask: how much is too much? And what the heck is a "quality adjusted life year" anyway?

Listen to the podcast here...

Labels: ,